Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 22 min ago
Peer-reviewedCC BYScientific Reports

Association between the CCR2-V64I polymorphism and cancer susceptibility: a meta-analysis of 20 case-control studies

  • Zhonghao Tang1
  • Si Shen1
  • Chen Guo1
  • Anjie Chen1
  • Dongjie Yang2
  • Yan Qin2
  • Yuanyuan Mi1
  1. 1Department of Urology, Affiliated Hospital of Jiangnan University
  2. 2Department of Pathology, Affiliated Hospital of Jiangnan University
Read full textPDFDOICite

Abstract

According to previous studies, the CCR2-V64I polymorphism has been associated with susceptibility to various cancers, yet this relationship remains controversial. To systematically evaluate this association, we conducted a meta-analysis to summarize and validate the available evidence. We comprehensively searched the PubMed, Embase, and Cochrane Library databases and ultimately included 20 case–control studies based on relevance and quality, comprising 4438 cases and 4874 controls. The association strength was analyzed using odds ratios and 95% confidence intervals. Overall analysis revealed a potential association between the CCR2-V64I polymorphism and cancer risk. Subgroup analyses by cancer type indicated that this polymorphism served as a risk factor for oral and bladder cancers, while exerting a protective effect against cervical cancer. Further organ-system-based stratification suggested that this polymorphism was associated with an increased risk of urinary system cancers and head and neck cancers. The results of ethnic subgroup analyses indicated that this polymorphism might be associated with a significantly elevated cancer risk in Caucasian populations. These findings demonstrated that the CCR2-V64I polymorphism may significantly influence cancer susceptibility.

Related

  1. Multi-ancestry genome- and transcriptome-wide association studies expand the susceptibility landscape for breast cancer overall and across subtypes
    Zheng Guo, Guochong Jia, Jie Ping +29
    Communications MedicinePeer-reviewedCC BY-NC-ND 4.0Full textGenetics & genomicsCrossref
  2. Association of MDM2 rs2279744 and rs937282 polymorphisms with breast cancer susceptibility and circulating MDM2 and p53 levels in Bangladeshi women: A case-control study
    Mahim Hassan Chowdhury, Farzana Islam, Adiba Ayesha Khan +8
    PLOS OnePeer-reviewedCC BY 4.0Full textGenetics & genomicsPLOS
  3. Transcriptome- and methylome-wide association studies prioritized lung cancer genes in East Asian populations
    Xingjie Hao, Minghan Qu, Yi Jiang +6
    PLOS GeneticsPeer-reviewedCC BY 4.0Full textMolecular biology & gene regulationGenetics & genomicsPLOS
  4. Association of regulatory B, T cells and cytokine production with disease stage in non-small cell lung cancer patients: prospective case control study.
    Helal F Hetta, Asmaa M Zahran, Emad Eldin Nabil +11
    BMC cancerPeer-reviewedCC BY-NC-NDFull textImmunologyEurope PMC
  5. CCR5Δ32 Polymorphism and Inflammatory Bowel Disease: A Case–Control and Genotype–Phenotype Study in a Polish Population
    Pawel Petryszyn, Klaudia Koj, Robert Dudkowiak +3
    International Journal of Molecular SciencesPeer-reviewedCC BY 4.0Genetics & genomicsCrossref

Cite

BibTeXRIS
BibTeX
@article{tang2026association,
  title = {{Association between the CCR2-V64I polymorphism and cancer susceptibility: a meta-analysis of 20 case-control studies}},
  author = {Zhonghao Tang and Si Shen and Chen Guo and Anjie Chen and Dongjie Yang and Yan Qin and Yuanyuan Mi},
  journal = {Scientific Reports},
  year = {2026},
  month = jul,
  doi = {10.1038/s41598-026-62138-6},
  url = {https://doi.org/10.1038/s41598-026-62138-6},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Association between the CCR2-V64I polymorphism and cancer susceptibility: a meta-analysis of 20 case-control studies
AU  - Zhonghao Tang
AU  - Si Shen
AU  - Chen Guo
AU  - Anjie Chen
AU  - Dongjie Yang
AU  - Yan Qin
AU  - Yuanyuan Mi
PY  - 2026
DA  - 2026/07/01
JO  - Scientific Reports
DO  - 10.1038/s41598-026-62138-6
UR  - https://doi.org/10.1038/s41598-026-62138-6
AB  - According to previous studies, the CCR2-V64I polymorphism has been associated with susceptibility to various cancers, yet this relationship remains controversial. To systematically evaluate this association, we conducted a meta-analysis to summarize and validate the available evidence. We comprehensively searched the PubMed, Embase, and Cochrane Library databases and ultimately included 20 case–control studies based on relevance and quality, comprising 4438 cases and 4874 controls. The association strength was analyzed using odds ratios and 95% confidence intervals. Overall analysis revealed a potential association between the CCR2-V64I polymorphism and cancer risk. Subgroup analyses by cancer type indicated that this polymorphism served as a risk factor for oral and bladder cancers, while exerting a protective effect against cervical cancer. Further organ-system-based stratification suggested that this polymorphism was associated with an increased risk of urinary system cancers and head and neck cancers. The results of ethnic subgroup analyses indicated that this polymorphism might be associated with a significantly elevated cancer risk in Caucasian populations. These findings demonstrated that the CCR2-V64I polymorphism may significantly influence cancer susceptibility.
SN  - 2045-2322
ER  -